Development of a Cu(II)-specific peptide shuttles capable of preventing Cu-Amyloid beta toxicity and importing bioavailable Cu into cells.

Abstract

Copper (Cu) in its ionic forms is an essential element for mammals and its homeostasis is tightly controlled. Accordingly, Cu-dyshomeostasis can be lethal as it is the case in the well-established genetic Wilson and Menkes diseases. In Alzheimer’s disease (AD), Cu-accumulation occurs in amyloid plaques, where it is bound to the amyloid-beta peptide (Aβ). In vitro, Cu-Aβ is competent to catalyze the production of reactive oxygen species (ROS) in presence of ascorbate under aerobic conditions, and hence Cu-Aβ is believed to contribute to the oxidative stress in AD. Several molecules that can recover extracellular Cu from Aβ and transport it back into cells with beneficial effects in cell culture and transgenic AD models were identified. However, all the Cu-shuttles currently available are not satisfactory due to various potential limitations including ion selectivity and toxicity. Hence, we designed a novel peptide-based Cu shuttle with the following properties: i) it contains a Cu(II)-binding motif that is very selective to Cu(II) over all other essential metal ions; ii) it is tagged with a fluorophore sensitive to Cu(II)-binding and release; iii) it is made of a peptide platform, which is very versatile to add new functions. The work presented here reports on the characterization of AKH-αR5W4NBD, which is able to transport Cu ions selectively into PC12 cells and the imported Cu appeared bioavailable, likely via reductive release induced by glutathione. Moreover, AKH-αR5W4NBD was able to withdraw Cu from Aβ1-16 peptide, and consequently inhibited the Cu-Aβ based reactive oxygen species production and related cell toxicity. Hence, AKH-αR5W4NBD could be a valuable new tool for Cu-transport into cells, and suitable for mechanistic studies in cell culture, with potential application in restoring Cu-homeostasis in Cu-related diseases such as AD.

Article information

Article type
Edge Article
Submitted
10 May 2022
Accepted
20 Sep 2022
First published
21 Sep 2022
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY-NC license

Chem. Sci., 2022, Accepted Manuscript

Development of a Cu(II)-specific peptide shuttles capable of preventing Cu-Amyloid beta toxicity and importing bioavailable Cu into cells.

M. Okafor, P. Gonzalez, P. Ronot, I. El Masoudi, A. Boos, S. Ory, S. Chasserot-Golaz, S. Gasman, L. Raibaut, C. Hureau, N. Vitale and P. Faller, Chem. Sci., 2022, Accepted Manuscript , DOI: 10.1039/D2SC02593K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements